Antibe Therapeutics

Antibe Therapeutics

Antibe Therapeutics

We are radically improving the safety & effectiveness of NSAIDs, the most widely used drugs for pain & inflammation.
Founded
2010
Raised
$3.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,400,000
Post-IPO equity - 2016
$786,000
Post-IPO equity - 2015
Team Size
10+
Employees
Location
Headquarters
$2,400,000 Post-IPO equity
businesswire

Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement | Business Wire